Polypharmacy was associated with a nearly doubled increase in health care expenditures and a tripled increase in pharmacy expenditures among older patients with cardiovascular diseases (CVD).

Although most clinicians instinctively try to avoid prescribing multiple medications concurrently, there is evidence that polypharmacy is increasing. Some estimates suggest up to 65% of U.S. adults ...

—It’s widely used in practice, but the evidence supporting the safety and efficacy of polypharmacy in patients with schizophrenia spectrum and other disorders may be missing some pieces. Antipsychotic ...

It is still unknown whether the relationship between polypharmacy and malnutrition is bidirectional and authors could not determine causation. Findings of a systematic review published in Clinical ...

In patients with acute HF, polypharmacy is common and associated with multimorbidity and older age. Polypharmacy is common globally among patients with acute heart failure (HF) and is associated with ...

A 77-year-old woman was referred to a geriatric day hospital with concerns about mobility and falls, pain, constipation, cognition and polypharmacy. Comorbidities included cerebrovascular disease, ...

Polypharmacy, or the concurrent use of five or more medications, is common in older adults and increases the risk of adverse drug interactions. While deprescribing unnecessary drugs can combat this ...

Global antipsychotic polypharmacy use increased significantly from 1970 to 2023, with 25% of antipsychotic users receiving multiple prescriptions, new research shows. Antipsychotic polypharmacy was ...

Depression and EGFR mutation status in stage IV non-small cell lung cancer. Background: To evaluate the prevalence of polypharmacy and the inappropriate prescribing of medications (IPM), and to ...

In today’s healthcare system, we stand at a critical crossroads when it comes to medication management. For decades, the practice of polypharmacy — prescribing multiple drugs to treat various symptoms ...

A study published in Pharmacoeconomics and Policy analyzed polypharmacy in Côte d'Ivoire using insurance data (2014−2018) and found a high prevalence ...